1635 studies found for:    breast,cancer,treatment | Open Studies
Show Display Options
Download search resultsDownload the search results for:
breast,cancer,treatment | Open Studies (1635 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery
Condition: Breast Cancer
Interventions: Radiation: Whole breast irradiation delivered by 3-dimensional conformal radiation therapy or intensity modulated radiation therapy;   Radiation: Higher per daily radiation therapy;   Radiation: Concurrent boost radiotherapy;   Radiation: Standard per daily radiation therapy;   Radiation: Sequential boost radiotherapy
2 Recruiting Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer
Conditions: Estrogen Receptor-positive Breast Cancer;   HER2-positive Breast Cancer;   Progesterone Receptor-positive Breast Cancer;   Stage IB Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer
Interventions: Drug: docetaxel;   Drug: carboplatin;   Biological: trastuzumab;   Biological: pertuzumab;   Drug: goserelin acetate;   Procedure: therapeutic conventional surgery;   Radiation: whole breast irradiation;   Procedure: quality-of-life assessment;   Other: laboratory biomarker analysis;   Drug: aromatase inhibition therapy
3 Recruiting Predictive Model of Therapy Outcomes in Breast Cancer Patients
Condition: Toxicity From Medication (Endocrine Treatment and Chemotherapy) Given for Breast Cancer Treatment.
Intervention:
4 Recruiting Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer
Conditions: Ductal Breast Carcinoma in Situ;   Lobular Breast Carcinoma in Situ;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer
Interventions: Procedure: neoadjuvant therapy;   Procedure: therapeutic conventional surgery;   Other: laboratory biomarker analysis;   Other: enzyme-linked immunosorbent assay;   Genetic: gene expression analysis;   Drug: systemic chemotherapy;   Drug: tamoxifen citrate;   Drug: aromatase inhibition therapy
5 Recruiting Radiation Therapy in Treating Post-Menopausal Women With Early Stage Breast Cancer Undergoing Surgery
Conditions: Ductal Breast Carcinoma in Situ;   Estrogen Receptor-negative Breast Cancer;   Estrogen Receptor-positive Breast Cancer;   HER2-negative Breast Cancer;   Invasive Ductal Breast Carcinoma;   Lobular Breast Carcinoma in Situ;   Progesterone Receptor-positive Breast Cancer;   Stage I Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIC Breast Cancer
Interventions: Procedure: therapeutic conventional surgery;   Radiation: radiation therapy;   Procedure: quality-of-life assessment
6 Recruiting Lymph Node Dissection and Radiation Therapy in Treating Patients With Breast Cancer Previously Treated With Chemotherapy and Surgery
Conditions: Lymphedema;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer
Interventions: Procedure: Axillary Lymph Node Dissection;   Radiation: Nodal Radiation Therapy;   Radiation: Axillary Radiation Therapy
7 Recruiting Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
Condition: Breast Cancer
Interventions: Procedure: palliative surgery;   Procedure: therapeutic conventional surgery;   Radiation: palliative radiation therapy;   Radiation: radiation therapy
8 Recruiting A Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2)
Condition: Breast Neoplasms
Interventions: Drug: PD-0332991;   Drug: Letrozole;   Drug: Placebo
9 Unknown  Radiation Therapy in Treating Women Who Have Undergone Breast Conservation Surgery and Systemic Therapy for Early Breast Cancer
Condition: Breast Cancer
Intervention: Radiation: intensity-modulated radiation therapy
10 Recruiting Adjuvant Treatment Recommendation and Oncotype DX® in Early Breast Cancer
Condition: Breast Cancer
Intervention:
11 Recruiting Safety of Breast Conserving Treatment in Locally Advanced Breast Cancer Receiving Neoadjuvant Treatment
Condition: Breast Cancer
Intervention:
12 Not yet recruiting Laser InGaAlP (660Nm) to Prevent Radiodermatitis in Breast Cancer Patients Submitted to Radiation Therapy
Conditions: Radiotherapy; Adverse Effect, Dermatitis or Eczema;   Breast Neoplasms
Interventions: Device: Laser therapy;   Device: Placebo
13 Recruiting Efficacy Study of Herceptin to Treat HER2-negative CTC Breast Cancer
Conditions: Breast Cancer;   Human Epidermal Growth Factor 2 Negative Carcinoma of Breast;   Circulating Tumor Cells
Intervention: Drug: trastuzumab
14 Unknown  Fulvestrant With or Without Lapatinib and/or Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer That Progressed After Previous Aromatase Inhibitor Therapy
Condition: Breast Cancer
Interventions: Drug: anastrozole;   Drug: exemestane;   Drug: fulvestrant;   Drug: lapatinib ditosylate;   Drug: letrozole;   Other: placebo
15 Not yet recruiting Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Olaparib;   Drug: Placebo
16 Recruiting A Pharmacokinetic and Randomized Trial of Neoadjuvant Treatment With Anastrozole Plus AZDO530 in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Anastrozole;   Drug: ADZ0530;   Drug: Placebo;   Procedure: Pharmacokinetic studies;   Procedure: Definitive Surgery;   Procedure: Core Biopsy;   Genetic: Tumor Tissue Collection for Genetic and Molecular Studies
17 Unknown  Combination Chemotherapy With or Without Darbepoetin Alfa in Treating Women With Stage III Breast Cancer
Condition: Breast Cancer
Interventions: Biological: darbepoetin alfa;   Drug: cyclophosphamide;   Drug: docetaxel;   Drug: doxorubicin hydrochloride;   Drug: epirubicin hydrochloride;   Drug: fluorouracil
18 Recruiting Early Detection and Intervention for Mild and Moderate Lymphedema in Patients Treated for Breast Cancer
Conditions: Lymphedema;   Breast Cancer
Interventions: Device: Compression Sleeve;   Device: Short-Stretch Compression Bandage
19 Recruiting KIS Study: a Study Evaluating the Effectiveness of an Internet-based Therapy Program for Sexuality and Intimacy Problems in Women Treated for Breast Cancer
Conditions: Sexual Dysfunction.;   Intimacy Problems.;   Breast Cancer Survivors.
Intervention: Behavioral: Internet-based cognitive behavioral therapy.
20 Not yet recruiting Omitting Completion Axillary Treatment in Sentinel Node Positive Breast Cancer Patients Undergoing a Mastectomy
Condition: Breast Neoplasms
Intervention: Procedure: Completion axillary treatment

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years